The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer

NCT07363382 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer (Adenocarcinoma)

Interventions

DRUG: 68Ga-G21
DRUG: 68Ga-G23

Sponsor

First Affiliated Hospital of Fujian Medical University